Mesenchymal Stem Cell Therapy for a Better Prognosis of Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mesenchymal stem cell (MSC) therapy is a frequently used treatment option for achieving a better prognosis in patients with heart failure (HF). However, due to reported adverse effects, patients are often hesitant to consider this treatment. Consequently, the aim of this systemic review and meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishna Mohan, Gautham Varun, Tirumandyam, Gayathri, Vemulapalli, Hema Srikanth, Vajje, Jaahnavi, Asif, Hamza, Saleem, Faraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479956/
https://www.ncbi.nlm.nih.gov/pubmed/37674948
http://dx.doi.org/10.7759/cureus.43037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479956/
https://www.ncbi.nlm.nih.gov/pubmed/37674948
http://dx.doi.org/10.7759/cureus.43037

Ejemplares similares